HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 278, Issue 8, 5702-5709, February 21, 2003

This Article Full Text Full Text (PDF) All Versions of this Article: 278/8/5702    most recent M207605200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roda, O. Articles by Navarro, P. Search for Related Content PubMed PubMed Citation Articles by Roda, O. Articles by Navarro, P. Social Bookmarking                      What's this?

New Insights into the tPA-Annexin A2 Interaction
IS ANNEXIN A2 CYS⁸ THE SOLE REQUIREMENT FOR THIS ASSOCIATION?^*

Oriol Roda^§¶, M. Luz Valero, Sandra Peiró, David Andreu, Francisco X. Real^§, and Pilar Navarro^§**

From the  Departament de Ciències Experimentales i de la Salut, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra, 08003-Barcelona, Spain and the ^§ Unitat de Biologia Cel·lular i Molecular, Institut Municipal d'Investigació Mèdica, 08003-Barcelona, Spain

Annexin A2 has been described as an important receptor for tissue-type plasminogen activator in endothelium and other cell types. Interaction between tissue-type plasminogen activator and its cellular receptor is critical for many of the functions of this protease. The annexin A2 motif that mediates tissue plasminogen activator interaction has been assigned to the hexapeptide LCKLSL in the amino-terminal domain of the protein, and it has been proposed that Cys⁸ of this sequence is essential for tPA binding. In an attempt to identify other amino acids critical for tPA-annexin A2 interaction, we have analyzed a set of peptides containing several modifications of the original hexapeptide, including glycine scans, alanine scans, D-amino acid scans, conservative mutations, cysteine blocking, and enantiomer and retroenantiomer sequences. Using a non-radioactive competitive binding assay, we have found that all cysteine-containing peptides, independently of their sequence, compete the interaction between tPA and annexin A2. Cysteine-containing peptides also inhibit tPA binding to the surface of cultured human umbilical vein endothelial cells (HUVEC). Mass spectrometry demonstrates that the peptides bind through a disulfide bond to a cysteine residue of annexin A2, the same mechanism that has been suggested for the inhibition mediated by homocysteine. These data call for a revision of the role of the LCKLSL sequence as the sole annexin A2 structural region required to bind tPA and indicate that further studies are necessary to better define the annexin A2-tPA interaction.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				E. Ortiz-Zapater, S. Peiro, O. Roda, J. M. Corominas, S. Aguilar, C. Ampurdanes, F. X. Real, and P. Navarro Tissue Plasminogen Activator Induces Pancreatic Cancer Cell Proliferation by a Non-Catalytic Mechanism That Requires Extracellular Signal-Regulated Kinase 1/2 Activation through Epidermal Growth Factor Receptor and Annexin A2 Am. J. Pathol., May 1, 2007; 170(5): 1573 - 1584. [Abstract] [Full Text] [PDF]

				A. Zinellu, S. Sotgia, L. Deiana, and C. Carru Quantification of Thiol-Containing Amino Acids Linked by Disulfides to LDL Clin. Chem., March 1, 2005; 51(3): 658 - 660. [Full Text] [PDF]

				S. Aguilar, J. M. Corominas, N. Malats, J. A. Pereira, M. Dufresne, F. X. Real, and P. Navarro Tissue Plasminogen Activator in Murine Exocrine Pancreas Cancer: Selective Expression in Ductal Tumors and Contribution to Cancer Progression Am. J. Pathol., October 1, 2004; 165(4): 1129 - 1139. [Abstract] [Full Text] [PDF]

				A. Lim, S. Sengupta, M. E. McComb, R. Theberge, W. G. Wilson, C. E. Costello, and D. W. Jacobsen In Vitro and in Vivo Interactions of Homocysteine with Human Plasma Transthyretin J. Biol. Chem., December 12, 2003; 278(50): 49707 - 49713. [Abstract] [Full Text] [PDF]

				T. J. MacLeod, M. Kwon, N. R. Filipenko, and D. M. Waisman Phospholipid-associated Annexin A2-S100A10 Heterotetramer and Its Subunits: CHARACTERIZATION OF THE INTERACTION WITH TISSUE PLASMINOGEN ACTIVATOR, PLASMINOGEN, AND PLASMIN J. Biol. Chem., July 3, 2003; 278(28): 25577 - 25584. [Abstract] [Full Text] [PDF]